RayzeBio, Inc. Common Stock
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of RayzeBio, Inc. Common Stock generated cash of -$51,681,000, which is less than the previous year. Cash used in financing activities reached the amount of $157,543,000 last year. Net change in cash is therefore $78,647,000.
Cash Flow
| 2020 | -2.33M | -3.60M | 149.80M |
|---|---|---|---|
| 2021 | -31.12M | -171.40M | 109.51M |
| 2022 | -51.68M | -27.21M | 157.54M |
RYZB Cash Flow Statement (2020 – 2022)
| 2022 | 2021 | 2020 | |
|---|---|---|---|
Cash at beginning of period | 50.85M | 143.86M | 0 |
Operating activities | |||
Net income | -68.6M | -29.44M | -6.91M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 1.53M | 455K | 213K |
Stock-based compensation expense | 6.32M | 1.99M | 29K |
| Deferred income tax benefit | 6.32M | 1.99M | 29K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 |
Cash generated by operating activities | -51.68M | -31.12M | -2.33M |
Investing activities | |||
Purchases Of Investments | -146.96M | -190.50M | -3.14M |
Investments In Property Plant And Equipment | -9.10M | -5.59M | -461K |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -27.21M | -171.40M | -3.60M |
Financing activities | |||
Common Stock Issued | 0 | 0 | 5K |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | -1.90M | -22K | 0 |
Repayments of term debt | 0 | 0 | 0 |
Cash used in financing activities | 157.54M | 109.51M | 149.80M |
Net Change In Cash | 78.64M | -93.01M | 143.86M |
Cash at end of period | 129.49M | 50.85M | 143.86M |